• Add this page to "Favorite pages"
  • Print the text(Open link in a new browser window)
Here begins the text.

Revisions of PRECAUTIONS (regenerative medical products)

PRECAUTIONS in package inserts include information such as Warning, Contraindications, Important Precautions, and Clinically Significant Adverse Reactions. When a new risk is identified, the Pharmaceuticals and Medical Devices Agency (PMDA) thoroughly investigates the risk and discusses a necessity of revision of PRECAUTIONS with expert advisors so that the PMDA can recommend an additional safety measure to the Ministry of Health, Labour and Welfare (MHLW). Following the investigation results from the PMDA, the MHLW issues a notice to revise PRECAUTIONS. Marketing authorization holders consequently revise PRECAUTIONS according to the notice.

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

  • Contact us
  • Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.

Revisions of PRECAUTIONS (regenerative medical products)